APA

Dubois V., Dasnois L., Lebtahi K., Collot F., Heylen N., Havaux N., Fernandez A., Lobl T. J., Oliyai C., Nieder M., Shochat D., Yarranton G. T. & Trouet A. (20020531). CPI-0004Na, a new extracellularly tumor-activated prodrug of doxorubicin: in vivo toxicity, activity, and tissue distribution confirm tumor cell selectivity. : Cancer research.

Chicago

Dubois Vincent, Dasnois Luc, Lebtahi Karim, Collot Françoise, Heylen Nathalie, Havaux Nathalie, Fernandez Anne-Marie, Lobl Thomas J, Oliyai Cecilia, Nieder Matthew, Shochat Dan, Yarranton Geoffrey T and Trouet André. 20020531. CPI-0004Na, a new extracellularly tumor-activated prodrug of doxorubicin: in vivo toxicity, activity, and tissue distribution confirm tumor cell selectivity. : Cancer research.

Harvard

Dubois V., Dasnois L., Lebtahi K., Collot F., Heylen N., Havaux N., Fernandez A., Lobl T. J., Oliyai C., Nieder M., Shochat D., Yarranton G. T. and Trouet A. (20020531). CPI-0004Na, a new extracellularly tumor-activated prodrug of doxorubicin: in vivo toxicity, activity, and tissue distribution confirm tumor cell selectivity. : Cancer research.

MLA

Dubois Vincent, Dasnois Luc, Lebtahi Karim, Collot Françoise, Heylen Nathalie, Havaux Nathalie, Fernandez Anne-Marie, Lobl Thomas J, Oliyai Cecilia, Nieder Matthew, Shochat Dan, Yarranton Geoffrey T and Trouet André. CPI-0004Na, a new extracellularly tumor-activated prodrug of doxorubicin: in vivo toxicity, activity, and tissue distribution confirm tumor cell selectivity. : Cancer research. 20020531.